ProKidney will be presenting at American Society of Nephrology’s Kidney Week 2023 on November 2-5, 2023, in Philadelphia, PA! Visit PROK’s booth (#938) during exhibit hours for additional information on REACT®. For more details, read the full release here: https://lnkd.in/eNaAqgsm #KidneyWk #ASN
ProKidney Corp.’s Post
More Relevant Posts
-
Busy at #DKK2024: We presented results from our studies PERSPECTIVE (@PREFERABLE consortium, funding EU-H2020), LIFT (funding Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation) and FIX. Tomorrow, watch out for our session on cancer-associated fatigue and our e-poster about the @PREFERABLE RCT EFFECT on exercise for mBC patients. DKFZ Deutsches Krebsforschungszentrum
To view or add a comment, sign in
-
Radiologic staging of ABPA Stage I: ABPA-S Stage II: ABPA with bronchiectasis Stage III: ABPA with high-attenuation mucus Stage IV: ABPA with chronic pleuropulmonary fibrosis MZeba (source:StatDx) https://lnkd.in/gaGCVtdG
To view or add a comment, sign in
-
🎙️Enjoy our latest episode of SurgOnc Today just released with experts discussing two key clinical scenarios during surveillance of pancreatic cystic neoplasms: when to pull the trigger on resection and if or when to discontinue surveillance. 👂https://ow.ly/s9pP50QwXbh
To view or add a comment, sign in
-
The Virtual VIVA app houses content from the 2023 conferences, including: - ALL VEINS sessions - VIVA's Global, Red, and Blue Theater sessions - 4 Pre-Courses - 5 live cases - 20 Late-Breaking clinical trial presentations Purchase conference content: https://lnkd.in/g_iMwsKw Preview 2 of 2023's Late-Breaking Clinical Trial presentations on our website: https://lnkd.in/gQckk-CA - Wound Assessment and Outcomes in the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit BTK™ Drug-Eluting Resorbable Scaffold - 5-Year Outcomes of the Gore® Viabahn® Endoprosthesis for the Treatment of Complex Femoropopliteal Lesions in a Japanese Population
To view or add a comment, sign in
-
Dr Hugh Calkins, Prof Riyaz Kaba, Prof Carlo de Asmundis, Prof Claudio Tondo and Dr Manuela Cirredu discuss the endocardial approach to managing arrhythmias and which patients may benefit💡 Discover bite-sized chapters from this on-demand symposium: Welcome and introduction 🔗 https://ow.ly/OVEZ50RFAx5 The hybrid approach to the management of arrhythmias – Which patients may benefit? 🔗 https://ow.ly/7RYk50RFAx7 Has PFA changed the approach to patient selection for hybrid ablation? 🔗 https://ow.ly/q2RQ50RFAx9 Review of atrial fibrillation guidelines – What they do and don’t say about hybrid ablation 🔗 https://ow.ly/MWkJ50RFAx6 Discussion – Current and future roles of hybrid ablation 🔗 https://ow.ly/Hjz250RFAx8 This programme is supported by an unrestricted educational grant from AtriCure, Inc.
To view or add a comment, sign in
-
Founder DRG PATH Labs, Partner & Director UNIDRG Specialty Labs (LLP)Delhi, Chairman Medical Advisory Committee Unipath Spl labs, Ahmedabad
Time to Tame The #Typhoid Disease free health, a relentless quest, To tame the typhoid, still a daunting test, A journey long, with trials to endure, A diagnostic dilemma, uncertain and obscure. Through ages past, the diagnostic battle goes on, #Stool assays tried, #Widal, #blood #culture , and so on #Molecular marvels, a new frontier, Promising hope, and holding near, In the brilliance of this new age, Will Typhoid's grip disengage. A fire burns to reach the goal, To conquer this strife, And have a healthy, typhoid-free life. So let us walk together , united strong, In the face of challenge, we'll march along, With science as our guiding light, We'll rise above this formidable fight. Though time may pass, our spirits won't wane, Together we'll seek, together we'll gain, The day will come, the typhoid's reign will cease, And all shall live in healthful peace. Please join to hear the experts today DRG Pathlab DRG Pathlab Unipath Specialty Laboratory Unipath Specialty Laboratory Limited - India Vanguard Diagnostics Partha Roy Dr Ashok Rattan Dr. Swati Maheshwari Veena Kohli Prof. Ashok Rattan
We are pleased to announce the inaugural edition of our three-part Webinar Series, delving into the realm of Typhoid Fever, its diagnosis, and public awareness. Organized in collaboration with Unipath Specialty Laboratory, this series has been commissioned by Vanguard Diagnostics and features esteemed industry experts: Dr. Partha Roy, Prof. Ashok Rattan, and Dr. Swati Maheshwari. The panel discussion will be moderated by the distinguished, Dr Ravi Gaur. Join us on Thursday, 20th July, at 3 pm Tune into the First Session of the Series using the link below: https://lnkd.in/dmq5Z47U Veena Kohli Dr.Ram Pramod Tiwari Anil Virmani Rahul Thakur
To view or add a comment, sign in
-
Hi everyone! I'm Shane De Vreese, one of the founders of Elemental. Today I'm visiting Dr. Lukas Wolschner in Vienna: 🗨 "It's always interesting to find new products that help with the healing, especially on the palate, because most of the patients try to avoid the donor site. They're scared of the pain. So Elemental can help us develop a surgical approach to reduce morbidity for the patient afterwards." ▶ Get started with Elemental at www.withelemental.com
To view or add a comment, sign in
-
Facilitator/Consultant/Coach ... ABC, CFRM, CLS, CCMT, CTM, GRI, NSA ... Sharpening your advantage by maximizing organizational capacity through individual leadership development
Congratulations, Therese Eutsler, PT II, CMTPT/DN, CCT, LHD, on completing MedBridge professional development course “Immunotherapy: What Every Rehab Professional Should Know.” The course’s learning objectives and goals: * Identify the use of immunotherapy in the oncologic patient populations * Identify the different types of immunotherapy, their indications, and their administration methods, * Recall common side effects of immunotherapy * Recognize how immunotherapy may affect and person’s functional mobility
To view or add a comment, sign in
-
Creative B2B marketing, communications and branding. Trend scout at the intersection of industry and design.
CENTOGENE's multiomic data insights support the end-to-end Pharma drug development workflow across all disease areas, especially rare and neurodegenerative. Learn how we support real-world evidence & registries for Fabry Disease with LaTina Green at the FSIG Expert Fabry Conference, and how we accelerate and de-risk clinical trials with Mario D'Alessandro at SCOPE!
Throughout the month of February, the CENTOGENE team is on the road – sharing our latest insights and advancements to accelerate diagnoses and treatment options for rare disease patients. The past days, LaTina Green, Peter Bauer, and Steffen Fischer were at WORLDSymposium, and we can't wait to meet more of you as our team continues their tour throughout the U.S. 𝗡𝗲𝘅𝘁 𝗨𝗽: 📍 Join LaTina Green at the 11th FSIG Expert Fabry Conference, in San Diego, California, on February 9-11 📍 Connect with Mario D'Alessandro at SCOPE 2024, taking place in Orlando, Florida, February 11-14 #Conference #Event #Networking #USA #WORLDSymposium #SCOPEsummit #Fabry #ClinicalTrial #DigitalHealth #RareDiseaseDay #RDD #RareIsMany #ShareYourColours #LightUpForRare #JoiningForces #RareDisease #Patients #Physicians #Pharma
To view or add a comment, sign in
2,866 followers